VEDOLIZUMAB RATES OF MUCOSAL HEALING IN CROHN'S DISEASE: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF REAL-WORLD

被引:0
|
作者
Danese, Silvio
Kamble, Pravin
Yang, Jin
Le Moine, Jean-Gabriel
Khan, Shahnaz
Hawe, Emma
Agboton, Christian
Wang, Song
Irving, Peter M.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su463
引用
收藏
页码:S702 / S703
页数:2
相关论文
共 50 条
  • [31] Real-world experience with cenobamate: A systematic review and meta-analysis
    Makridis, Konstantin L.
    Kaindl, Angela M.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023, 112 : 1 - 10
  • [32] Real-World Effectiveness of Vedolizumab as Induction Therapy in Inflammatory Bowel Disease: A Meta-Analysis
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Khalid, Javaria
    Loftus, Edward, Jr.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S24 - S24
  • [33] VEDOLIZUMAB DOSE ESCALATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE EXPERIENCING LOSS OF RESPONSE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF REAL-WORLD EVIDENCE
    Varghese, Della
    Patel, Dipen
    Martin, Stephan
    Luo, Michelle
    Ursos, Lyann
    Lirio, Richard A.
    Wang, Song
    GASTROENTEROLOGY, 2020, 158 (06) : S406 - S407
  • [34] Vedolizumab dose escalation in patients with inflammatory bowel disease experiencing loss of response: A systematic review and meta-analysis of real-world evidence
    Varghese, D.
    Patel, D.
    Martin, S.
    Luo, M.
    Ursos, L.
    Lirio, R.
    Wang, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S524 - S525
  • [35] Real-world subcutaneous infliximab for inflammatory bowel disease: A systematic review and meta-analysis
    Chetwood, J.
    Tran, Y.
    Subramanian, S.
    Smith, P.
    Iborra Colomino, M.
    Buisson, A.
    Paramsothy, S.
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 160 - 161
  • [36] Treatment of Mammary Paget Disease: A systematic review and meta-analysis of real-world data
    Lin, Cheng-Wei
    Chiang, Meng-Hsuan
    Tam, Ka-Wai
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 107
  • [37] Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis
    Attauabi, M.
    Madsen, G. R.
    Bendtsen, F.
    Seidelin, J. B.
    Burisch, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I483 - I484
  • [38] HEALING OF PERINEAL WOUNDS AFTER PROCTECTOMY FOR CROHN'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Alipouriani, Ali
    Erozkan, Kamil
    Schabl, Lukas
    Holubar, Stefan D.
    GASTROENTEROLOGY, 2024, 166 (05) : S1836 - S1836
  • [39] Healing of Perineal Wounds after Proctectomy for Crohn's Disease: A Systematic Review and Meta-Analysis
    Alipouriani, A.
    Erozkan, K.
    Schabl, L.
    Holubar, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I631 - I631
  • [40] Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis
    Attauabi, M.
    Madsen, G. R.
    Bendtsen, F.
    Seidelin, J. B.
    Burisch, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I483 - I484